Regression of paclitaxel-induced maculopathy with oral acetazolamide
- 227 Downloads
Malignant melanoma is a highly aggressive skin cancer, characterized by a rising incidence and the early occurrence of metastases. Because of its pronounced resistance to therapies in advanced stages of disease, extensive research is done to find new effective therapeutic concepts.
KeywordsPaclitaxel Optical Coherence Tomography Sorafenib Macular Edema Acetazolamide
- 5.Hauschild A, Agarwala SS, Trefzer U, Hogg D, Robert C, Hersey P, Eggermont A, Grabbe S, Gonzalez R, Gille J, Peschel C, Schadendorf D, Garbe C, O'Day S, Daud A, White JM, Xia C, Patel K, Kirkwood JM, Keilholz U (2009) Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma. J Clin Oncol 27:2823–2830PubMedCrossRefGoogle Scholar